List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

Editact Company

Editact specializes in the development of novel gene treatments for Alzheimer's disease. It focuses on unmet clinical requirements in familial Alzheimer's disease (FAD) and is developing "one-to-many" gene editing therapeutics.

Investors

Founded Date: 2023
Industry: Gene Therapies (Age related diseases treatment)
Headquarters: Hong Kong
Register and Claim Ownership